SynAct Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 6 750 | 6,9 | SEK | 46 575 | 2024-03-20 |
| 2024-03-25 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Dividend distributed | 977 256 | 6,9 | SEK | 6 743 066,4 | 2024-03-20 |
| 2024-03-25 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Dividend received | 186 334 | 6,9 | SEK | 1 285 704,6 | 2024-03-20 |
| 2024-03-25 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Acquisition | 14 250 | 6,9 | SEK | 98 325 | 2024-03-20 |
| 2024-03-25 | SynAct Pharma AB | Jeppe Øvlesen | Chief Executive Officer (CEO)/Managing Directory | Dividend received | 245 870 | 6,9 | SEK | 1 696 503 | 2024-03-20 |
| 2024-04-30 | SynAct Pharma AB | Anders Kronborg | Member of the Board of Directors | Subscription | 34 883 | 8,6 | SEK | 299 993,8 | 2024-04-29 |
| 2024-05-02 | SynAct Pharma AB | Sten Scheibye | Member of the Board of Directors | Subscription | 132 093 | 8,6 | SEK | 1 135 999,8 | 2024-05-01 |
| 2024-05-03 | SynAct Pharma AB | Sten R. Sörensen | Member of the Board of Directors | Subscription | 11 627 | 8,6 | SEK | 99 992,2 | 2024-05-01 |
| 2024-05-06 | SynAct Pharma AB | Björn Westberg | Chief Financial Officer (CFO) | Subscription | 12 000 | 8,6 | SEK | 103 200 | 2024-05-02 |
| 2024-05-06 | SynAct Pharma AB | Jeppe Øvlesen | Member of the Board of Directors | Subscription | 58 139 | 8,6 | SEK | 499 995,4 | 2024-04-29 |
| 2024-05-08 | SynAct Pharma AB | Thomas Jonassen | Other member of the company's administrative, management or supervisory body | Subscription | 58 139 | 8,6 | SEK | 499 995,4 | 2024-05-07 |
| 2024-05-08 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Subscription | 18 604 | 8,6 | EUR | 159 994,4 | 2024-05-07 |
| 2024-06-04 | SynAct Pharma AB | Björn Westberg | Chief Financial Officer (CFO) | Allotment | 516 205 | 0 | SEK | 0 | 2024-05-31 |
| 2024-06-05 | SynAct Pharma AB | Jeppe Oevlesen | Chief Executive Officer (CEO)/Managing Directory | Allotment | 722 688 | 0 | SEK | 0 | 2024-06-02 |
| 2024-06-05 | SynAct Pharma AB | Anders Kronborg | Chairman of the Board of Directors | Allotment | 330 371 | 0 | SEK | 0 | 2024-05-31 |
| 2024-06-05 | SynAct Pharma AB | Kirsten Harting | Other member of the company's administrative, management or supervisory body | Allotment | 103 240 | 0 | SEK | 0 | 2024-06-02 |
| 2024-06-05 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Allotment | 309 723 | 0 | SEK | 0 | 2024-05-31 |
| 2024-06-05 | SynAct Pharma AB | Sten Scheibye | Member of the Board of Directors | Allotment | 132 093 | 0 | SEK | 0 | 2024-05-31 |
| 2024-06-05 | SynAct Pharma AB | Sten Sörensen | Member of the Board of Directors | Allotment | 247 778 | 0 | SEK | 0 | 2024-05-31 |
| 2024-06-06 | SynAct Pharma AB | Thomas Jonassen | Other member of the company's administrative, management or supervisory body | Allotment | 516 205 | 0 | SEK | 0 | 2024-06-02 |